Overview
Mark Fluchel is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Fluchel is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Histiocytosis, and Reticulohistiocytoma.
His clinical research consists of co-authoring 44 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 2 clinical trials in the study of Medulloblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Fluchel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Phillip Barnette is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Barnette is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Leukemia, Hepatoblastoma, and Bone Marrow Aspiration.
Primary Children's Hospital - Hematology Oncology
Dr. Dietz received his degrees in medicine and medical education from the University of New England. He completed his Pediatric Residency and Hematology and Oncology Fellowship at Oregon Health & Science University where he also served as chief resident.In 2020 Dr. Dietz joined the faculty of the University of Utah, where he is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Clinically, Dr. Dietz focuses on the care of pediatric and young adult patients with bone and soft tissue sarcoma, as well as children with retinoblastoma. He is the Associate Director of the Primary Children's Hospital Solid Tumor Program and leads the Comprehensive Retinoblastoma Program. Dr. Dietz is committed to delivering cutting edge clinical care, as well as providing patients with access to experimental therapeutics and discovery programs.�Dr. Dietz's research efforts include team science approaches to better understand the biology driving cancer progression and treatment resistance with a focus on translating this work into new therapies. He is a member of the Huntsman Cancer Institute's Experimental Therapeutics Program and actively involved in the development of early phase clinical trials through multiple cooperative consortia including the Children's Oncology Group, The Sunshine Project, the Pediatric Oncology Experimental Therapeutics Investigator's Consortium, and the Pediatric Early Phase Clinical Trial Network. Dr. Dietz is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Ewing Sarcoma, Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.
Carol Bruggers is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Bruggers is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Ganglioglioma, Rhabdoid Tumor, Glioma, and Teratoma of the Mediastinum.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hemophagocytic LymphohistiocytosisDr. Fluchel isAdvanced. Learn about Hemophagocytic Lymphohistiocytosis.
- HistiocytosisDr. Fluchel isAdvanced. Learn about Histiocytosis.
- Juvenile Myelomonocytic Leukemia (JMML)
- Non-Langerhans-Cell HistiocytosisDr. Fluchel isAdvanced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaDr. Fluchel isAdvanced. Learn about Reticulohistiocytoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Fluchel isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Embryonal Tumor with Multilayered Rosettes
- Evans SyndromeDr. Fluchel isExperienced. Learn about Evans Syndrome.
- Ewing SarcomaDr. Fluchel isExperienced. Learn about Ewing Sarcoma.
- GliomaDr. Fluchel isExperienced. Learn about Glioma.
- Langerhans Cell HistiocytosisDr. Fluchel isExperienced. Learn about Langerhans Cell Histiocytosis.